The National Health Insurance Authority (NHIA) has introduced a cost-sharing initiative, subsidising up to N400,000 for eligible cancer patients undergoing radiotherapy, to help reduce the financial burden of cancer treatment and improve access to care.
The Director-General of the NHIA, Dr Kelechi Ohiri stated this on Wednesday in Abuja.
Ohiri noted that the move was in recognition of the high cost of radiotherapy, an essential part of cancer treatment, as the world observed World Cancer Day.
“This initiative is part of the authority’s broader strategy to make cancer treatment more accessible and affordable for Nigerians,” Ohiri said.
He added that radiotherapy, a vital treatment for various cancers, particularly in advanced stages, had often been out of reach for many due to its prohibitive costs.
“To address this, the NHIA is now offering a 50 per cent subsidy on radiotherapy expenses, capped at N400,000.
Ohiri emphasised that the NHIA’s partnership with multiple oncology facilities across Nigeria aimed to improve access to high-quality radiotherapy services.
“The authority is also focused on increasing the number of accredited radiotherapy centres, strengthening collaborations with pharmaceutical and medical equipment companies, and ensuring modern radiotherapy technology is available nationwide.
“Beyond radiotherapy, the NHIA is broadening its coverage of oncology services.
“Through its formal sector programme and the Group Individual and Family Social Health Insurance Programme (GIFSHIP), the NHIA provides access to a wide range of cancer care services.
“The services include access to diagnostic tools such as tumour marker assays, MRI, CT scans, mammography, ultrasound, histology, and endoscopy.
“Coverage for oncology-related surgeries such as mastectomies and prostatectomies and access to both fully and partially covered chemotherapy drugs through the NHIA’s cost-sharing model.”
Ohiri said that the NHIA was also collaborating with pharmaceutical giants like Roche Limited and Pfizer to introduce cost-sharing for oncology medicines.
“This initiative has already benefited over 200 patients receiving care at seven tertiary care centres across the country.
“NHIA is working to expand its partnerships with other pharmaceutical companies to broaden access to cancer treatments.
“NHIA is focusing on building a sustainable healthcare infrastructure for cancer care by contracting service providers capable of offering comprehensive oncology services, expanding access to advanced diagnostic services, and increasing the number of accredited oncology centres across Nigeria.”
In support of the initiative, Dr Adamu Umar, former President of the Nigerian Cancer Society (NCS), lauded the NHIA for its efforts to improve access to cancer care, calling it a significant step forward.
He highlighted that radiotherapy is crucial, particularly for patients in advanced stages, and added that the NHIA’s cost-sharing model would help alleviate the financial strain on both patients and their families.
“The NHIA’s initiative is a step in the right direction, and more patients must benefit from such programmes,” Umar added.
NAN
